Gene · 259307
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment. | Biochem Biophys Rep | 2025 | 40734997 | PubTator, text mining | PubMed |
| The Venom Proteome of the Ecologically Divergent Australian Elapid, Southern Death Adder Acanthophis antarcticus. | Toxins (Basel) | 2025 | 40711163 | PubTator, text mining | PubMed |
| Ontogenetic influence in Crotalus durissus ruruima snake venom: an intermediate between north and south venom pattern of rattlesnake. | Toxicon | 2025 | 40614827 | PubTator, text mining | PubMed |
| PM2.5 Induced Nasal Mucosal Barrier Dysfunction and Epithelial-Mesenchymal Transition to Promote Chronic Rhinosinusitis Through IL4I1-AhR Signaling Pathway. | Toxics | 2025 | 40559961 | PubTator, text mining | PubMed |
| Biochemical and proteomic profiling reveals potent proteolytic activity in the venom of Erythrolamprus melanotus (Shaw's dark ground snake, Xenodontini). | Biochimie | 2025 | 40480311 | PubTator, text mining | PubMed |
| Venomic and F(ab')₂ antivenomic studies of Bothrops alternatus venom proteins. | Int J Biol Macromol | 2025 | 40451370 | PubTator, text mining | PubMed |
| Vp1 protein peptide molecule and LAAO in liver cancer gene therapy: VN-NsLAAO fusion protein regulates mir-149-RAS liver cancer cell proliferation pathway. | Int J Biol Macromol | 2025 | 40451362 | PubTator, text mining | PubMed |
| Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance. | Discov Oncol | 2025 | 40397318 | PubTator, text mining | PubMed |
| Macrophage sensitivity to bexmarilimab-induced reprogramming is shaped by the tumor microenvironment. | J Immunother Cancer | 2025 | 40379271 | PubTator, text mining | PubMed |
| Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer. | Transl Androl Urol | 2025 | 40376539 | PubTator, text mining | PubMed |
| Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synuclein. | NPJ Parkinsons Dis | 2025 | 40368950 | PubTator, text mining | PubMed |
| IL4I1 knockdown inhibits the epithelial-mesenchymal transition process in glioma via downregulation of the JAK2/STAT3 signaling pathway. | Neoplasma | 2025 | 40353627 | PubTator, text mining | PubMed |
| Comparative study on drug encapsulation and release kinetics in extracellular vesicles loaded with snake venom L - amino acid oxidase. | BMC Pharmacol Toxicol | 2025 | 40340782 | PubTator, text mining | PubMed |
| Immunohistochemical Profiling of IDO1 and IL4I1 in Head and Neck Squamous Cell Carcinoma: Interplay for Metabolic Reprogramming? | Int J Mol Sci | 2025 | 40332319 | PubTator, text mining | PubMed |
| Co-immobilization of LAAO and Pt NPs in HOFs: An enzyme-metal coupled catalysis for enhancing the one-pot synthesis of α-keto acid. | Int J Biol Macromol | 2025 | 40319982 | PubTator, text mining | PubMed |
| Engineered Macrophage Membrane-Camouflaged Nanodecoys Reshape the Infectious Microenvironment for Efficient Periodontitis Treatment. | ACS Nano | 2025 | 40228155 | PubTator, text mining | PubMed |
| Gallium-Magnesium Layered Double Hydroxide for Elevated Tumor Immunotherapy Through Multi-Network Synergistic Regulation. | Adv Mater | 2025 | 40190140 | PubTator, text mining | PubMed |
| Differential Effects of IL4I1 Protein on Lymphocytes From Healthy and Multiple Sclerosis Patients. | Pharmacol Res Perspect | 2025 | 40102177 | PubTator, text mining | PubMed |
| Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results. | Signal Transduct Target Ther | 2025 | 40097400 | PubTator, text mining | PubMed |
| Spatial Metabolomics and Transcriptomics Reveal Metabolic Reprogramming and Cellular Interactions in Nasopharyngeal Carcinoma with High PD-1 Expression and Therapeutic Response. | Theranostics | 2025 | 40083932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259307/papers?page=5